Compass Pathways fell on Phase 3 data but remains on track for an FDA filing despite dilution risks and volatility. Find out ...

The new rule comes after a public advisory committee meeting in May that reviewed data showing risks for patients who use opioids over long periods. Those risks include misuse, addiction and overdoses ...

Other states have enacted similar laws that would strip artificial dyes from school meals, but West Virginia's action is the ...

U.S. health officials are cracking down on an opioid-related ingredient being added to drinks, supplements and other products ...

The Food and Drug Administration (FDA) on Tuesday said it is recommending a scheduling action to control certain ...

Laura Loomer reportedly set up a "tip line" for staffers eager to see their "disloyal" colleagues purged. Trump has been ...

The FDA has released a report to educate the public regarding the dangers of 7-OH and its distinction from the kratom plant ...

The U.S. Food and Drug Administration is taking significant steps in the ongoing fight against the Opioid Crisis.

The Food and Drug Administration (FDA) is requiring class-wide label changes for opioid medications to provide additional information on the risks associated with long-term use.

The FDA has announced new requirements for safety labeling on all opioid pain medications that place renewed emphasis on the risks associated with their long-term use. According to a July 31 news ...

Die-hard Trump supporter Laura Loomer has reportedly set up a tip line for supporters of the president to report their ...

The FDA recommendation follows a detailed scientific review and is part of broader efforts to address concerns about the rise of 7-OH opioid products. Currently, 7-OH has no FDA-approved drug uses and ...